Understanding the risk of ionizing radiation in breast imaging: Concepts and quantities, clinical importance, and future directions
- PMID: 39423780
- PMCID: PMC12148680
- DOI: 10.1016/j.ejrad.2024.111784
Understanding the risk of ionizing radiation in breast imaging: Concepts and quantities, clinical importance, and future directions
Abstract
Background: Conventional mammography remains the primary imaging modality for state-of-the-art breast imaging practice and its benefit (both on diagnostic and screening) was largely reported. In mammography, the typical Mean Glandular Dose (MGD) from X-ray radiation to the breast spans, on average, from 1 to 10 mGy, depending on breast thicknesses, percentage of fibroglandular tissue, and on the examination purpose.
Methods: The aim of this narrative review is to describe the extent of radiation risk in X-ray breast imaging and discuss the main steps and parameters (e.g. MGD, screening frequency and number of examination views) that may have an influence on the radiation risk assessment.
Results: Even though the radiation doses used with these examinations are very low, as compared to other medical or natural radiation exposures, there is a non-negligible associated risk of radiation-induced cancer. Accurate radiation risk assessment permits to better balance the overall estimation of the benefit-to-risk ratio in X-ray breast imaging.
Conclusions: It is expected that a better knowledge about radiation-induced cancer risk among population could improve the communications skills between patients and clinicians and could help to increase the awareness in women about radiation risk perception for a transparent and proper informed choice of imaging exam.
Keywords: Absorbed dose; Low doses; Mammography; Radiation-induced cancer risk.
Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Dai JY, Luebeck EG, Chang ET, Clarke CA, Hubbell EA, Zhang N and Duffy SW, “Strong association between reduction of late-stage cancers and reduction of cancer-specific mortality in meta-regression of randomized screening trials across multiple cancer types,” Journal of Medical Screening, 26 May 2024; DOI: 10.1177/09691413241256744. - DOI - PMC - PubMed
-
- W. H. Organization, “Existence of national screening program for breast cancer,” [Online]. Available: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/exist.... [Accessed 11 06 2024].
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical